bluebird bio

First gene therapy drug sets million-euro price record

The Western world's first gene therapy drug is set to go on sale in Germany with a 1.1 million euro ($1.4 million) price tag, a new record for a medicine to treat a rare disease.

Read Full Article

bluebird bio Announces Closing of IPO

bluebird bio Inc. announced closing of its initial public offering after selling 6,832,352 shares priced at US$17 per share piece.

Read Full Article

bluebird bio Secures $60 Million in Oversubscribed Financing

bluebird bio today announced the successful completion of a $60 million Series D financing.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics